MG PHARMA
0427.381.406 · rovalta.com · 23/09/2026
MG PHARMA
Overview
What does MG PHARMA do?
MG PHARMA is a Private company with limited liability incorporated in 1985. Its registered office is in Forest.
1190 Forest · BruxellesSee on map
Trend over 17 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 19,5 k € | -66.1% | 57,6 k € | +39.9% | 41,2 k € | +23.6% | 33,3 k € | -37.0% | 52,9 k € | -17.3% | 63,9 k € | -13.6% | 74 k € | +15.4% | 64,1 k € | -5.9% | 68,1 k € | +18.3% | 57,6 k € | -29.5% | 81,7 k € | +1432% | -6,1 k € | +30.9% | -8,9 k € | -3134% | 292,7 € | -95.3% | 6,3 k € | +5.2% | 6 k € | +6.4% | 5,6 k € |
| EBITDA | 19,5 k € | -66.1% | 57,6 k € | +39.9% | 41,2 k € | +23.6% | 33,3 k € | -34.2% | 50,6 k € | -17.3% | 61,2 k € | -14.6% | 71,7 k € | +15.4% | 62,2 k € | -7.5% | 67,2 k € | +19.5% | 56,2 k € | -30.5% | 80,8 k € | +1347% | -6,5 k € | +52.0% | -13,5 k € | -24560% | -54,8 € | -101% | 4,3 k € | -27.2% | 6 k € | +13.6% | 5,2 k € |
| Operating result | 8,9 k € | -81.0% | 47 k € | +53.7% | 30,6 k € | +34.6% | 22,7 k € | -43.2% | 40 k € | -20.9% | 50,6 k € | -17.1% | 61,1 k € | +20.1% | 50,9 k € | -9.0% | 55,9 k € | +35.4% | 41,3 k € | -38.0% | 66,6 k € | +1127% | -6,5 k € | +52.0% | -13,5 k € | -612% | -1,9 k € | -176% | 2,5 k € | +15.7% | 2,2 k € | +62.1% | 1,3 k € |
| Net result | -3,8 k € | -119% | 19,8 k € | +3572% | 538 € | -87.5% | 4,3 k € | -37.1% | 6,8 k € | -63.0% | 18,4 k € | +58.7% | 11,6 k € | -49.0% | 22,8 k € | +77.9% | 12,8 k € | +196% | 4,3 k € | +115% | -28,5 k € | -336% | -6,5 k € | -107% | 88,5 k € | +5522% | -1,6 k € | -172% | 2,3 k € | +120% | 1 k € | +197% | -1,1 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 167,8 k € | -2.2% | 171,6 k € | +13.0% | 151,9 k € | -16.0% | 180,8 k € | +36.7% | 132,3 k € | +5.4% | 125,4 k € | +17.2% | 107 k € | +12.2% | 95,4 k € | +31.4% | 72,6 k € | +21.4% | 59,8 k € | +7.8% | 55,5 k € | -34.0% | 84 k € | -7.2% | 90,5 k € | +4430% | 2 k € | -45.0% | 3,6 k € | +168% | 1,4 k € | +323% | 319,9 € |
| Total assets | 1,1 M € | +6.1% | 1 M € | -5.9% | 1,1 M € | -16.4% | 1,3 M € | +12.7% | 1,2 M € | -1.5% | 1,2 M € | +1.7% | 1,2 M € | +2.9% | 1,1 M € | -1.5% | 1,2 M € | -1.5% | 1,2 M € | +3.4% | 1,1 M € | +95.5% | 579 k € | +539% | 90,6 k € | +131% | 39,3 k € | -10.0% | 43,7 k € | +0.7% | 43,4 k € | -3.8% | 45,1 k € |
| Cash | 6,3 k € | +74.1% | 3,6 k € | +1598% | 212,7 € | -99.2% | 25,4 k € | +184% | 8,9 k € | -22.6% | 11,6 k € | -41.2% | 19,6 k € | +10.4% | 17,8 k € | +4.4% | 17 k € | -30.1% | 24,4 k € | +13.1% | 21,5 k € | -6.3% | 23 k € | +168% | 8,6 k € | +92.6% | 4,4 k € | -51.0% | 9,1 k € | +4.5% | 8,7 k € | +11.0% | 7,8 k € |
| Debts | 933 k € | +7.7% | 865,9 k € | -8.9% | 950,2 k € | -16.4% | 1,1 M € | +9.7% | 1 M € | -2.4% | 1,1 M € | +0.1% | 1,1 M € | +2.0% | 1 M € | -3.7% | 1,1 M € | -2.8% | 1,1 M € | +3.1% | 1,1 M € | +117% | 495 k € | +1262655% | 39,2 € | -99.9% | 37,3 k € | -6.8% | 40 k € | -4.7% | 42 k € | -6.1% | 44,8 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2021 · 1 active · 6 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/02/2024 | 14/10/2022 | 22/06/2021 | 15/11/2022 | 12/07/2019 | 28/09/2018 |
| General meeting | 30/06/2023 | 15/06/2022 | 15/06/2021 | 01/09/2021 | 30/06/2019 | 30/06/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
18 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2022 | 30/06/2023 | 27/02/2024 | French | |
| Abridged model | 31/12/2021 | 15/06/2022 | 14/10/2022 | French | |
| Abridged model | 31/12/2020 | 15/06/2021 | 22/06/2021 | French | |
| Abridged modelCorrection | 31/12/2019 | 01/09/2021 | 15/11/2022 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 22/06/2021 | French | |
| Abridged model | 31/12/2018 | 30/06/2019 | 12/07/2019 | French | |
| Abridged model | 31/12/2017 | 30/06/2018 | 28/09/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 28/09/2018 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 11/10/2016 | French | |
| Abridged model | 31/12/2014 | 30/06/2015 | 23/12/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 23/12/2015 | French | |
| Abridged model | 31/12/2012 | 30/06/2013 | 08/10/2013 | French | |
| Abridged model | 31/12/2011 | 16/06/2012 | 24/01/2013 | French | |
| Abridged model | 31/12/2010 | 18/06/2011 | 13/08/2011 | French | |
| Abridged model | 31/12/2009 | 19/06/2010 | 26/08/2010 | French | |
| Abridged model | 31/12/2008 | 20/06/2009 | 03/08/2009 | French | |
| Abridged model | 31/12/2007 | 21/06/2008 | 30/07/2008 | French | |
| Abridged model | 31/12/2006 | 16/06/2007 | 31/07/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2021 · 1 active · 6 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates06/01/2012DENOMINATION - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022-3,8 k €↓
- 2021Annual accounts 202119,8 k €↑
- 2020Annual accounts 2020538 €↓
- 2019Annual accounts 20194,3 k €↓
- 2018Annual accounts 20186,8 k €↓
- 2017Annual accounts 201718,4 k €↑
- 2016Annual accounts 201611,6 k €↓
- 2015Annual accounts 201522,8 k €↑
- 2014Annual accounts 201412,8 k €↑
- 2013Annual accounts 20134,3 k €↑
- 2012Annual accounts 2012-28,5 k €↓
- 2011Annual accounts 2011-6,5 k €↓
- 2011Name changeMG PHARMA
- 2010Annual accounts 201088,5 k €↑
- 2009Annual accounts 2009-1,6 k €↓
- 2008Annual accounts 20082,3 k €↑
- 2007Annual accounts 20071 k €↑
- 2006Annual accounts 2006-1,1 k €
- 2006Name changeVEREECKE ET ROLAND
- 04/06/1985IncorporationPrivate company with limited liability